News
We are excited to share that Cardiomyopathy UK who are collaborating with us for our patient survey, has sent out their research newsletter to 730 subscribers. The newsletter links to…
In May 2024 we met with patient organisations from the United Kingdom, Ireland and Finland and we are happy to announce that SMASH-HCM is now working with Cardiomyopathy UK. Cardiomyopathy…
We had the opportunity to present our project and our work on Digital Twin technology for hypertrophic cardiomyopathy (HCM) at the International Conference & the 29th Finnish National Conference on…
A recent study published in the International Journal of Cardiology highlights innovative findings on ventricular arrhythmias (VA) risk profiles in hypertrophic cardiomyopathy (HCM). The study, led by a research team…
On May 15th, 2024, the SMASH-HCM project team met with patient organisations from the United Kingdom, Ireland, Finland, and Italy to discuss our innovative approach to improving the stratification and…
Thrilled to announce the kick-off of the SMASH-HCM project! Hypertrophic Cardiomyopathy (HCM), a common inherited heart disease, presents diverse risks but is currently diagnosed and treated as a single condition….